Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Mar 2015 07:00 AM
RNS
New Ordinary Shares
16 Feb 2015 07:00 AM
RNS
Trading Update
30 Jan 2015 11:57 AM
RNS
Holding(s) in Company
28 Jan 2015 12:05 PM
RNS
Grant of Options
09 Jan 2015 07:00 AM
RNS
Directors' Dealings
06 Jan 2015 07:00 AM
RNS
Directorate Change
23 Dec 2014 07:00 AM
RNS
Year End Update
10 Dec 2014 07:00 AM
RNS
Innovenn Board Appointment
25 Nov 2014 02:30 PM
RNS
Trading Update
20 Nov 2014 07:00 AM
RNS
Innovenn commences production at new facilities
11 Nov 2014 07:00 AM
RNS
EUR1.4m contract win with US firm
06 Nov 2014 07:00 AM
RNS
Director's Dealings
04 Nov 2014 07:00 AM
RNS
Directors' Dealings
21 Oct 2014 07:00 AM
RNS
EUR1.2m Contract with Global Pharmaceutical Comp
07 Oct 2014 07:00 AM
RNS
Board Change
30 Sep 2014 07:01 AM
RNS
Strategic Investment in InnoVenn
30 Sep 2014 07:00 AM
RNS
Interim Results
25 Sep 2014 07:00 AM
RNS
Half Yearly Report
18 Sep 2014 11:29 AM
RNS
Holding(s) in Company
08 Sep 2014 03:00 PM
RNS
Issue of Consideration Shares
08 Sep 2014 07:00 AM
RNS
EUR2.4m contract for pan-European coronary study
05 Sep 2014 07:00 AM
RNS
Notification of Major Interest in Shares
05 Sep 2014 07:00 AM
RNS
Notification of Major Interest in Shares
04 Sep 2014 07:00 AM
RNS
Notification of Major Interest in Shares
01 Sep 2014 02:05 PM
RNS
Result of General Meeting
26 Aug 2014 07:00 AM
RNS
Notification of Major Interest in Shares
21 Aug 2014 07:00 AM
RNS
hVIVO HCM of GS-5806 in RSV for Gilead Sciences
14 Aug 2014 07:00 AM
RNS
Conditional Placing to raise ?33.6 million
05 Aug 2014 07:00 AM
RNS
Acquisition of French CRO
28 Jul 2014 07:00 AM
RNS
hVIVO HCM of AL-8176 in RSV for Alios BioPharma
14 Jul 2014 07:00 AM
RNS
Board Change
04 Jul 2014 07:00 AM
RNS
Notification of Major Interest in Shares
26 Jun 2014 07:00 AM
RNS
Board Change
24 Jun 2014 03:44 PM
RNS
Result of AGM
24 Jun 2014 07:00 AM
RNS
AGM Statement
19 Jun 2014 07:00 AM
RNS
Skin science patent grant
12 Jun 2014 07:00 AM
RNS
Board Changes
04 Jun 2014 07:00 AM
RNS
Start of hVIVO Challenge Study in Asthma
02 Jun 2014 07:00 AM
RNS
Investor Event
27 May 2014 02:26 PM
RNS
Director's Dealing
21 May 2014 04:00 PM
RNS
Result of AGM
16 May 2014 12:25 PM
RNS
Major contract win
16 May 2014 12:23 PM
RNS
Final Results
12 May 2014 07:00 AM
RNS
Notification of Major Interest in Shares
01 May 2014 07:00 AM
RNS
Notification of Major Interest in Shares
17 Apr 2014 02:00 PM
RNS
2013 Annual Report and Accounts
09 Apr 2014 07:01 AM
RNS
Board Changes
09 Apr 2014 07:00 AM
RNS
Audited 2013 Preliminary Results
02 Apr 2014 12:21 PM
RNS
Holding(s) in Company
31 Mar 2014 11:48 AM
RNS
Result of general meeting

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings